Sanoliving Inc
$279,975.00 CAD
- Department
- National Research Council Canada
- Recipient country
- Canada
- Fiscal year
- 2026-2027
- Agreement period
- April 1, 2026 – December 16, 2026
- Reference
- nrc-cnrc:172-2026-2027-Q1-1042236
Published purpose
sanoLiving is conducting an integrated R&D program to advance and validate their existing Clinical Decision Support Framework (CDSF), an AI tool that helps clinicians deliver consistent, evidence-based midlife women’s care. The new R&D adds a clinician-supervised learning loop and outcomes-based evaluation to improve accuracy and transparency within a privacy-preserving secure architecture. Building on a guideline-grounded generative AI base, they will test whether longitudinal outcomes can improve the reliable, explainable recommendations in real clinical workflows. The outcome will be avalidated MVP and a repeatable privacy, governance, and evaluation framework that creates Canadian IP and strengthens Canada’s health AI capability.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.